The kinetic disposition of azlocillin in patients with end stage renal failure was evaluated in six individuals maintained on chronic extracorporeal haemodialysis and in six individuals on peritoneal dialysis. In the absence of renal function the plasma half-life of azlocillin was extended from the normal value of approximately 60 min to 235 + 30 min. During peritoneal dialysis the plasma half-life was reduced to 148 ± 15 min and during extracorporeal haemodialysis it was further reduced to 112±11 min. Azlocillin was readily dialysed during haemodialysis but its removal rate during peritoneal dialysis was substantially less
The pharmacokinetics of oxacillin and dicloxacillin, with and without the co-administration of mezlo...
Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltra...
Ten adult patients on continuous ambulatory peritoneal dialysis (CAPO) received one dose of trimetho...
Systemic and urinary pharmacokinetic studies of the disposition of azlocillin were performed in seve...
Azlocillin (Securopen) and mezlocillin (Baypen) were given to 3 healthy subjects as intravenous infu...
The pharmacokinetics of amoxicillin was investigated in 4 healthy volunteers and in 16 patients with...
◆ Background: Azithromycin is an azalide antibiotic with a similar antibacterial spectrum to erythro...
This paper presents data on the absorption and dis-appearance of a new semisynthetic antibiotic-amox...
Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics. Aztreonam, a new monob...
The pharmacokinetic disposition of Chlorpheniramine was evaluated in hemodialysis and peritoneal dia...
GRAM-NEGATIVE bacterial infections fre-quently complicate the management of patients undergoing peri...
The pharmacokinetics of netilmicin after i.v. administration were studied in 10 adult hemodialyzed p...
Dibekacin pharmcokinetics was studied in 3 healthy volunteers, 5 patients with renal failure present...
Dibekacin pharmacokinetics was studied in 3 healthy volunteers, 5 patients with renal failure presen...
Beta2-microglobulin kinetics in end-stage renal failure. The kinetics of β-microglobulin (β2m) were ...
The pharmacokinetics of oxacillin and dicloxacillin, with and without the co-administration of mezlo...
Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltra...
Ten adult patients on continuous ambulatory peritoneal dialysis (CAPO) received one dose of trimetho...
Systemic and urinary pharmacokinetic studies of the disposition of azlocillin were performed in seve...
Azlocillin (Securopen) and mezlocillin (Baypen) were given to 3 healthy subjects as intravenous infu...
The pharmacokinetics of amoxicillin was investigated in 4 healthy volunteers and in 16 patients with...
◆ Background: Azithromycin is an azalide antibiotic with a similar antibacterial spectrum to erythro...
This paper presents data on the absorption and dis-appearance of a new semisynthetic antibiotic-amox...
Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics. Aztreonam, a new monob...
The pharmacokinetic disposition of Chlorpheniramine was evaluated in hemodialysis and peritoneal dia...
GRAM-NEGATIVE bacterial infections fre-quently complicate the management of patients undergoing peri...
The pharmacokinetics of netilmicin after i.v. administration were studied in 10 adult hemodialyzed p...
Dibekacin pharmcokinetics was studied in 3 healthy volunteers, 5 patients with renal failure present...
Dibekacin pharmacokinetics was studied in 3 healthy volunteers, 5 patients with renal failure presen...
Beta2-microglobulin kinetics in end-stage renal failure. The kinetics of β-microglobulin (β2m) were ...
The pharmacokinetics of oxacillin and dicloxacillin, with and without the co-administration of mezlo...
Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltra...
Ten adult patients on continuous ambulatory peritoneal dialysis (CAPO) received one dose of trimetho...